期刊文献+

Crystal Structure and Anticancer Properties of Cinobufagin 3-Hemisuberate Methyl Ester 被引量:1

Crystal Structure and Anticancer Properties of Cinobufagin 3-Hemisuberate Methyl Ester
下载PDF
导出
摘要 The title compound cinobufagin 3-hemisuberate methyl ester(1) was isolated from the venom of Bufo bufo gargarizans CANTOR. The crystal structure of 1, C35H48O9, was determined by single-crystal X-ray diffraction analysis. It belongs to orthorhombic, space group P212121 with a = 8.9338(3), b = 16.2970(4), c = 22.4019(6) , V = 3261.59(16) 3, Mr = 612.73, Z = 4, Dc = 1.248 g/cm3, μ = 0.725 mm-1, F(000) = 1320, S = 1.040, the final R = 0.0374 and wR = 0.0412 for 4458 unique reflections, of which 4088 were observed(I 〉 2σ(I)). In the solid state, short intermolecular C-H...O interactions involving a methine and the ester carbonyl group in cinobufagin moiety and a methyl in the suberate moiety linked adjacent molecules into a three-dimensional network. Detailed analysis of the 1H-NMR data showed that X-ray structure of 1 would be expected to closely resemble the solution conformation in chloroform. Compound 1 was inactive for the inhibition of PC3 and HepG2 cancer cells, but the parent compound cinobufagin showed potent inhibition with IC50 values of 0.145 and 5.48 μM, respectively, indicating that esterification at C(3) decreased the cytotoxic effect of 1. The title compound cinobufagin 3-hemisuberate methyl ester(1) was isolated from the venom of Bufo bufo gargarizans CANTOR. The crystal structure of 1, C35H48O9, was determined by single-crystal X-ray diffraction analysis. It belongs to orthorhombic, space group P212121 with a = 8.9338(3), b = 16.2970(4), c = 22.4019(6) , V = 3261.59(16) 3, Mr = 612.73, Z = 4, Dc = 1.248 g/cm3, μ = 0.725 mm-1, F(000) = 1320, S = 1.040, the final R = 0.0374 and wR = 0.0412 for 4458 unique reflections, of which 4088 were observed(I 〉 2σ(I)). In the solid state, short intermolecular C-H...O interactions involving a methine and the ester carbonyl group in cinobufagin moiety and a methyl in the suberate moiety linked adjacent molecules into a three-dimensional network. Detailed analysis of the 1H-NMR data showed that X-ray structure of 1 would be expected to closely resemble the solution conformation in chloroform. Compound 1 was inactive for the inhibition of PC3 and HepG2 cancer cells, but the parent compound cinobufagin showed potent inhibition with IC50 values of 0.145 and 5.48 μM, respectively, indicating that esterification at C(3) decreased the cytotoxic effect of 1.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2014年第5期790-794,共5页 结构化学(英文)
基金 supported by the National Natural Science Foundation of China(81102518)
关键词 crystal structure cinobufagin 3-hemisuberate methyl ester ANTICANCER crystal structure,cinobufagin 3-hemisuberate methyl ester,anticancer
  • 相关文献

参考文献17

  • 1Editorial Committee of the State Administration of Traditional Chinese Medicine. ZhonghuaBencao. Shanghai Science and Technology Press: Shanghai 1999, pp. 362-367.
  • 2China Pharmacopoeia Committee. Chinese Pharmacopoeia (2010 Edition). Chemical Industry Press: Beijing 2010, 360.
  • 3Steyn, P. S.; van Heerden, F. R. Bufadienolides of plant and animal origin. Nat. Prod. Rep. 1998, 15, 397-413.
  • 4Gao, H. M.; Popescu, R.; Kopp, B.; Wang, Z. M. Bufadienolides and their antitumor activity. Nat. Prod. Rep. 2011, 28, 953-969.
  • 5Roger, J. B.; Brian, J. P.; Roxanne, R. S.;Amitava, D. Effects of ChanSu, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: cardiotoxicity due to more than Na+, K+-ATPase blocking. Life sci. 2002, 72, 699-709.
  • 6Wansapura, A. N.; Lasko, V.; Xie, Z.; Fedorova, O. V.; Bagrov, A. Y.; Lingrel, J. B.; Lorenz, J. N. Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alphal Na+K+-ATPase. Am. J. Physiol. Heart Circ. Physiol. 2009, 296, H1833-1839.
  • 7Yu, C. H.; Kan, S. F.; Pu, H. F.; Chien, E. J.; Wang, P. S. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells. Cancer Sci. 2008, 99, 2467-2476.
  • 8Tian, H. Y.; Wang, L.; Zhang, X. Q.; Zhang, D. M.; Wang, Y.; Jiang, R. W.; Ye, W. C. New bufadienolides and C23 steroids from the venom of Bufo bufo gargarizans.Steroids 2010, 75, 884-890.
  • 9Tian, H. Y.; Wang, L.; Zhang, X. Q.; Wang, Y.; Zhang, D. M.; Jiang, R. W.; Liu, Z.; Liu, J. S.; Li, Y. L.; Ye, W. C. Bufogargarizins A and B, two novel 19-norbufadienolides with unprecedented skeletons from the venom of Bufo bufo gargarizans. Chem. Eur. J. 2010, 16, 10989-10993.
  • 10Tian, H. Y.; Luo, S. L.; Liu, J. S.; Wang, L.; Wang, Y.; Zhang, D. M.; Zhang, X. Q.; Jiang, R. W.;Ye, W. C. C23 Steroids from the venom of Bufo bufo gargarizans. J. Nat. Prod. 2013, 76, 1842-1847.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部